Abbott Laboratories (SIX: ABT.SW) Stock Competitors & Peer Comparison
See ABT.SW's competitors and their performance on the SIX and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ABT.SW and its SIX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ABT.SW | CHF 72.50 | -2.68% | 125.5B | 19.79 | CHF 3.66 | +2.78% |
| SOON.SW | CHF 276.80 | -0.86% | 16.6B | 30.62 | CHF 9.10 | +1.69% |
| ZBH.SW | CHF 75.00 | -3.23% | 14.5B | 12.13 | CHF 6.19 | +1.04% |
| MED.SW | CHF 90.10 | +5.13% | 1.1B | 73.08 | CHF 1.20 | N/A |
| KURN.SW | CHF 19.44 | +15.37% | 743.1M | 103.48 | CHF 0.18 | N/A |
| METN.SW | CHF 852.00 | -0.12% | 379.5M | -35.20 | -CHF 24.06 | N/A |
| SHLTN.SW | CHF 1.07 | +0.00% | 38.4M | -0.60 | -CHF 1.71 | N/A |
Stock Comparison
Sonova Holding AG (SIX: SOON.SW)
ABT.SW vs SOON.SW Comparison October 2026
Abbott Laboratories (SIX: ABT.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABT.SW stands at 125.5B. In comparison, SOON.SW has a market cap of 16.6B. Regarding current trading prices, ABT.SW is priced at CHF 72.50 on the SIX, while SOON.SW trades at CHF 276.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABT.SW currently has a P/E ratio of 19.79, whereas SOON.SW's P/E ratio is 30.62. In terms of profitability, ABT.SW's ROE is +0.11%, compared to SOON.SW's ROE of +0.17%. Regarding short-term risk, ABT.SW is less volatile compared to SOON.SW. This indicates lower risk in terms of short-term price fluctuations for ABT.SW.Check SOON.SW's competition here